Argent BioPharma Ltd.

About Argent BioPharma Ltd.

Argent BioPharma is a specialized biopharmaceutical company focused on developing and marketing innovative drugs using advanced nanotechnology and a multidisciplinary R&D approach. The company aims to address unmet medical needs, particularly in the central nervous system (CNS) and immune-related diseases, with a vision to become a globally recognized leader in transforming patient outcomes through effective therapies.

Products & Services

Epilepsy Treatment:Medicines targeting epilepsy, a central nervous system disorder causing seizures due to abnormal brain activity.

Dementia Treatment:Therapies for dementia, a condition involving loss of cognitive functioning that interferes with daily life.

Covid-19 Treatment:Medicines for Covid-19, an infectious disease caused by the SARS-CoV-2 virus.

Crohn's Disease Treatment:Treatments for Crohn's disease, an inflammatory bowel disease causing chronic inflammation of the gastrointestinal tract.

Cancer Treatment:Therapies targeting cancer, a group of diseases involving abnormal cell growth.

Specialties

Nanotechnology in Drug Development Central Nervous System (CNS) Therapies Autoimmune System Therapies Multidisciplinary Research Methods Multi-targeted Drug Therapies Precision Nanoscale Delivery

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Placement T: - FT: Placement	A: 4500000 MR: - FA: US$4,500,000 FAN: 4500000	D: 2025-01-07 FD: 2025-01-07	-
2	RT: Placement T: - FT: Placement	A: 4500000 MR: - FA: US$4,500,000 FAN: 4500000	D: 2025-01-06 FD: 2025-01-06	-

Placement Latest

2025-01-07

$4.5M

Placement 2025-01-06

$4.5M

View 1 more funding rounds with Pro

Unlock Full Funding History

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

R

Rowan Harland

Company Secretary

LinkedIn (Pro only)

R

Roby Zomer

Managing Director and CEO

LinkedIn (Pro only)

D

Dan Robinson

Non Executive Director

LinkedIn (Pro only)

G

Gary Hermon

Non-Executive Director

I

Igor Bluvstein

Chief Financial Officer

A

Amir Polak

Chief Pharmaceutical Development Officer

View 6 more team members with Pro

Unlock Full Team Directory

Recent News